Anika to Participate in the Sidoti Small Cap Virtual Investor Conference
On June 10, 2022, Anika Therapeutics (NASDAQ: ANIK) announced participation in the Sidoti Small Cap Virtual Investor Conference on June 15, 2022. The management will host a virtual presentation with a Q&A session starting at 11:30 am ET. Investors can access the webcast through the Investor Relations section of Anika's website and an archived version will also be available later. Anika focuses on joint preservation and offers innovative solutions in early intervention orthopedics, including products for osteoarthritis pain management.
- None.
- None.
BEDFORD, Mass., June 10, 2022 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early intervention orthopedics, today announced that management will participate in the Sidoti Small Cap Virtual Investor Conference on Wednesday, June 15, 2022. Anika will host a virtual presentation with Q&A starting at 11:30am ET.
Webcast of the presentation and Q&A will be available in the Investor Relations section of Anika’s website, www.anika.com. An archive of the presentation will also be available on the website.
About Anika
Anika Therapeutics, Inc. (NASDAQ: ANIK), is a global joint preservation company that creates and delivers meaningful advancements in early intervention orthopedic care. Leveraging our core expertise in hyaluronic acid and implant solutions, we partner with clinicians to provide minimally invasive products that restore active living for people around the world. Our focus is on high opportunity spaces within orthopedics, including osteoarthritis pain management, regenerative solutions, sports medicine soft tissue repair and bone preserving joint technologies, and our products are efficiently delivered in key sites of care, including ambulatory surgery centers. Anika’s global operations are headquartered outside of Boston, Massachusetts. For more information about Anika, please visit www.anika.com.
ANIKA, ANIKA THERAPEUTICS and the Anika logo are registered trademarks of Anika Therapeutics, Inc.
For Investor Inquiries:
Anika Therapeutics, Inc.
Mark Namaroff, 781-457-9287
Vice President, Investor Relations, ESG and Corporate Communications
investorrelations@anika.com
FAQ
When is the Anika Therapeutics presentation at the Sidoti Small Cap Virtual Investor Conference?
How can I watch the Anika Therapeutics investor presentation?
What is the focus area of Anika Therapeutics?
Where is Anika Therapeutics headquartered?